NASDAQ: GRI - GRI Bio, Inc.

Yield per half year: -52.62%
Sector: Healthcare

Share chart GRI Bio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

GRI Bio, Inc., биофармацевтическая компания клинической стадии, специализируется на лечении воспалительных, фиброзных и аутоиммунных заболеваний в Соединенных Штатах. В портфель продуктов компании входят GRI-0621, который находится на стадии II клинической разработки для лечения идиопатического легочного фиброза; GRI-0803, который проходит фазу I испытаний по лечению системной красной волчанки; GRI-0124, находящийся в доклинической разработке для лечения первичного склерозирующего холангита; и GRI-0729 в ​​доклинической разработке.

more details
Компания также разрабатывает ADAIR и ADMIR для лечения синдрома дефицита внимания и гиперактивности. GRI Bio, Inc. ранее была известна как Glycoregimmune, Inc. GRI Bio, Inc. была основана в 2009 году и базируется в Лос-Анджелес-Хойя, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-02-10
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.gribio.com
Цена ао 0.7525
Change price per day: -1.02% (0.785)
Change price per week: +5% (0.74)
Change price per month: +2.24% (0.76)
Change price per 3 month: +74.22% (0.446)
Change price per half year: -52.62% (1.64)
Change price per year: -71.17% (2.695)
Change price per 3 year: -84.55% (5.03)
Change price per 5 year: 0% (0.777)
Change price per 10 year: 0% (0.777)
Change price per year to date: -1.65% (0.79)
All parameters

Underestimation

Title Value Grade
P/S 0.6522 10
P/BV 54.81 1
P/E 0 0
EV/EBITDA -1.09 0
Total: 5.13

Efficiency

Title Value Grade
ROA, % -441.04 0
ROE, % -5033.59 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0012 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 21667 10
Yield Ebitda, % 240.56 10
Yield EPS, % -73.56 0
Total: 8
More

Institutions Volume Share, %
Altium Capital Management, LP 74501 1.65
Stratos Wealth Partners, Ltd. 3571 0.08
HRT Financial LP 3425 0.08
Vanguard Group Inc 2648 0.06
Geode Capital Management, LLC 2124 0.05
Tower Research Capital LLC (TRC) 1062 0.02
UBS Group AG 342 0.01
Wells Fargo & Company 2 0

ETF Share, % Profitability for 1 year, % Dividends, %
SPDR Dow Jones International Real Estate ETF 0.54326 -14.87 4.62416
Dimensional International Small Cap Value ETF 0.33137 4.56 4.55441
DBX ETF Trust - Xtrackers International Real Estate ETF 0.23773 -8.63 4.01983
WisdomTree International SmallCap Dividend Fund 0.17136 8.52 5.22973
WisdomTree Dynamic Currency Hedged International SmallCap Equity Fund 0.16295 5.52 5.2239
SPDR Dow Jones Global Real Estate ETF 0.15319 -1.97 4.1185
Schwab International Small-Cap Equity ETF 0.10471 10.07 3.20638
Dimensional International Small Cap ETF 0.10078 3.21 3.34747
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.07311 -1 3.5165
Vanguard FTSE All-World ex-US Small-Cap ETF 0.07 9.39 3.09932
Schwab Fundamental International Small Co. Index ETF 0.03575 8.31 3.46652
Dimensional International Core Equity 2 ETF 0.03471 3.33 3.69996
Avantis Responsible International Equity ETF 0.03104 17.44 3.61591
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.02317 1.05 3.85434
Dimensional World ex U.S. Core Equity 2 ETF 0.01949 13.06 3.62488
Avantis International Equity ETF 0.01689 3.14 3.80856
SPDR Portfolio Europe ETF 0.01577 8.94 3.66537
WisdomTree Dynamic Currency Hedged International Equity Fund 0.01553 8 4.7092
Dimensional International Core Equity Market ETF 0.01321 13.09 3.48343
Vanguard ESG International Stock ETF 0.01 4.9 3.07501



Head Job title Payment Year of birth
Dr. W. Marc Hertz Ph.D. President & Director 842.01k 1970 (55 years)
Ms. Leanne M. Kelly CFO & Corporate Secretary 550.93k 1977 (48 years)
Dr. Vipin Kumar Chaturvedi Ph.D. Co-Founder & Chief Scientific Officer N/A 1959 (66 years)
Dr. Albert Agro Ph.d. Co-Founder & Chief Medical Officer 461.1k 1965 (60 years)
Ms. Cristina Gil White Interim Chief Executive Officer

Address: United States, LA Jolla. CA, 2223 Avenida de la Playa - open in Google maps, open in Yandex maps
Website: https://www.gribio.com